Jalyn

Product manufactured by Glaxosmithkline Llc

Application Nr Approved Date Route Status External Links
NDA022460 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Jalyn Is A Combination Of Dutasteride, A 5-Alpha-Reductase Inhibitor, And Tamsulosin, An Alpha-Adrenergic Antagonist, Indicated For The Treatment Of Symptomatic Benign Prostatic Hyperplasia (Bph) In Men With An Enlarged Prostate. ( 1.1 ) Limitations Of Use: Dutasteride-Containing Products, Including Jalyn, Are Not Approved For The Prevention Of Prostate Cancer. ( 1.2 ) 1.1 Benign Prostatic Hyperplasia (Bph) Treatment Jalyn (Dutasteride And Tamsulosin Hydrochloride) Capsules Are Indicated For The Treatment Of Symptomatic Bph In Men With An Enlarged Prostate. 1.2 Limitations Of Use Dutasteride-Containing Products, Including Jalyn, Are Not Approved For The Prevention Of Prostate Cancer.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Comments